Toll Free Number Toll Free: 1800 103 1369 Email Us Email Us: customercare@canmoney.in
Market


Income Statement

You can view the Income Statement for the last 5 years.



INCOME STATEMENT

Alembic Pharmaceuticals Ltd.

GO
Market Cap. ( ₹ in Cr. ) 20248.95 P/BV 3.46 Book Value ( ₹ ) 297.45
52 Week High/Low ( ₹ ) 1073/636 FV/ML 2/1 P/E(X) 30.01
Book Closure 29/07/2026 EPS ( ₹ ) 34.33 Div Yield (%) 1.16
(₹ in Crs.)

ParticularsMar 26Mar 25Mar 24Mar 23Mar 22
Months1212121212
Source Of Info (AR = Annual Report, PR = Press Release)ARARARARAR
FaceValue2.002.002.002.002.00
      
      
INCOME     
Revenue From Operations [Net]7212.616539.716112.115499.775231.79
Other Operating Revenues132.29132.37116.51152.8574.00
Total Operating Revenues7344.906672.086228.625652.625305.79
      
Other Income54.4142.5528.312.7450.46
Total Revenue7399.316714.636256.935655.365356.25
      
EXPENSES     
Cost Of Materials Consumed1747.381672.171403.011250.081129.11
Purchase Of Stock-In Trade508.88410.96454.91380.09360.50
Operating And Direct Expenses63.020.000.0050.900.00
Changes In Inventories Of FG,WIP And Stock-In Trade-271.81-289.77-142.8478.65-43.19
Employee Benefit Expenses1731.931562.341446.291169.131133.00
Finance Costs93.6378.7756.1950.1717.73
Depreciation And Amortisation Expenses318.55278.58272.67275.43286.78
Other Expenses2447.032308.142133.902015.391852.21
Total Expenses6638.616021.195624.135269.844736.14
      
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax760.70693.44632.80385.52620.11
      
Exceptional Items-66.9912.870.000.000.00
Profit/Loss Before Tax693.71706.31632.80385.52620.11
      
Tax Expenses-Continued Operations     
Current Tax127.60122.6965.814.20129.18
Deferred Tax-104.482.99-46.069.20-23.47
Tax For Earlier Years0.00-0.51-3.75-0.79-1.25
Total Tax Expenses23.12125.1716.0012.61104.46
Profit/Loss After Tax And Before ExtraOrdinary Items670.59581.14616.80372.91515.65
      
Profit/Loss From Continuing Operations670.59581.14616.80372.91515.65
      
Profit/Loss For The Period670.59581.14616.80372.91515.65
      
Minority Interest3.941.410.000.000.00
Share Of Profit/Loss Of Associates0.240.87-0.98-30.925.29
Consolidated Profit/Loss After MI And Associates674.77583.42615.82341.99520.94
      
OTHER INFORMATION     
      
EARNINGS PER SHARE     
Basic EPS (Rs.)34.3329.6831.3317.4026.50
Diluted EPS (Rs.)34.3329.6831.3317.4026.50
      
DIVIDEND AND DIVIDEND PERCENTAGE     
Equity Share Dividend216.22216.22157.25196.56275.19
ParticularsMar 26
Months12
Source Of Info (AR = Annual Report, PR = Press Release)AR
FaceValue2.00
  
INCOME 
Revenue From Operations [Net]7212.61
Other Operating Revenues132.29
Total Operating Revenues7344.90
Other Income54.41
Total Revenue7399.31
EXPENSES 
Cost Of Materials Consumed1747.38
Purchase Of Stock-In Trade508.88
Operating And Direct Expenses63.02
Changes In Inventories Of FG,WIP And Stock-In Trade-271.81
Employee Benefit Expenses1731.93
Finance Costs93.63
Depreciation And Amortisation Expenses318.55
Other Expenses2447.03
Total Expenses6638.61
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax760.70
Exceptional Items-66.99
Profit/Loss Before Tax693.71
Tax Expenses-Continued Operations 
Current Tax127.60
Deferred Tax-104.48
Tax For Earlier Years0.00
Total Tax Expenses23.12
Profit/Loss After Tax And Before ExtraOrdinary Items670.59
Profit/Loss From Continuing Operations670.59
Profit/Loss For The Period670.59
Minority Interest3.94
Share Of Profit/Loss Of Associates0.24
Consolidated Profit/Loss After MI And Associates674.77
OTHER INFORMATION 
EARNINGS PER SHARE 
Basic EPS (Rs.)34.33
Diluted EPS (Rs.)34.33
DIVIDEND AND DIVIDEND PERCENTAGE 
Equity Share Dividend216.22